CVM Research and Charts

CVM - CEL-SCI Corp (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-13 (Delayed quote data 2025-09-12)

Last 10.15	Change ⇑ +0.33 (+3.31%)	Volume 93,603
	Open 9.95	High 10.46	Low 9.80

8EMA (Daily) 10.31	40EMA (Daily) 8.83	50EMA (Daily) 8.40	STO (Daily) 32.950	MACD Hist (Daily) -0.500
8EMA (Weekly) 8.888	40EMA (Weekly) 11.62	50EMA (Weekly) 14.45	STO (Weekly) 77.376	MACD Hist (Weekly) 2.543


Company Profile
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.